We are live on ! Find out more
CCRN icon

Cross Country Healthcare

162 hedge funds and large institutions have $478M invested in Cross Country Healthcare in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 66 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

409% more call options, than puts

Call options by funds: $163K | Put options by funds: $32K

3.08% less ownership

Funds ownership: 102.42%99.35% (-3.1%)

7% less funds holding

Funds holding: 175162 (-13)

11% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 66

28% less capital invested

Capital invested by funds: $666M → $478M (-$188M)

41% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 29

Holders
162
Holders Change
-13
Holders Change %
-7.43%
% of All Funds
2.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
59
Reduced
66
Closed
29
Calls
$163K
Puts
$32K
Net Calls
+$131K
Net Calls Change
-$28K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$82M +$1.77M +112,028 +2%
Pacer Advisors
2
Pacer Advisors
Pennsylvania
$63M +$2.61M +165,032 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$34.6M +$61.1K +3,858 +0.2%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$32.7M +$386K +24,363 +1%
WA
5
Wasatch Advisors
Utah
$24.3M -$6.11M -385,882 -18%
SFM
6
Systematic Financial Management
New Jersey
$21.2M -$955K -60,310 -4%
State Street
7
State Street
Massachusetts
$18.4M -$1.38M -87,111 -6%
ACB
8
Aristotle Capital Boston
Massachusetts
$12.6M -$225K -14,202 -2%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$10.9M +$311K +19,656 +3%
American Century Companies
10
American Century Companies
Missouri
$10.7M +$1.68M +106,226 +16%
RA
11
Royce & Associates
New York
$10.4M -$1.86M -117,502 -14%
Morgan Stanley
12
Morgan Stanley
New York
$8.07M -$536K -33,871 -5%
Invesco
13
Invesco
Georgia
$7.17M +$722K +45,585 +10%
Deutsche Bank
14
Deutsche Bank
Germany
$7.12M -$3.12M -197,152 -28%
Bank of America
15
Bank of America
North Carolina
$6.35M +$3.23M +204,325 +80%
Charles Schwab
16
Charles Schwab
California
$6.23M -$476K -30,097 -6%
Citadel Advisors
17
Citadel Advisors
Florida
$5.67M +$72.8K +4,598 +1%
DIA
18
Dana Investment Advisors
Wisconsin
$5.6M +$1.65M +104,136 +35%
Northern Trust
19
Northern Trust
Illinois
$5.19M -$156K -9,851 -3%
UBS Group
20
UBS Group
Switzerland
$5.05M +$5.34M +337,214 +1,217%
LSV Asset Management
21
LSV Asset Management
Illinois
$4.7M
BCM
22
Bridgeway Capital Management
Texas
$4.63M -$1.45M -91,360 -21%
CAM
23
Congress Asset Management
Massachusetts
$4.6M -$49.4K -3,122 -0.9%
AQR Capital Management
24
AQR Capital Management
Connecticut
$4.46M +$1.46M +92,011 +40%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$4.22M +$144K +9,090 +3%

CCRN Hedge Fund Activity: Q2 2024 in Review

162 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Cross Country Healthcare (CCRN) for Q2 2024, worth a combined $478M — down 28% from $666M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CCRN and 17 opened new positions — a net loss of 12 holders — while 66 trimmed existing stakes and 59 added.

The largest buyer was UBS Group, adding an estimated $5.34M. The largest seller was Wellington Management Group, exiting entirely with an estimated $6.47M sold.

  • 162 institutional investors held Cross Country Healthcare (CCRN) as of Q2 2024, down from 175 in Q1 2024.
  • Funds reported $478M of Cross Country Healthcare stock for Q2 2024, down 28% quarter-over-quarter.
  • 17 funds opened new Cross Country Healthcare positions in Q2 2024 and 29 closed out, a net change of -12 holders.
  • The largest Cross Country Healthcare buyer in Q2 2024 was UBS Group, an estimated $5.34M added.
  • The largest Cross Country Healthcare seller in Q2 2024 was Wellington Management Group, an estimated $6.47M sold.

Based on aggregated 13F filings for Q2 2024.